Deputy Director of the Comprehensive Research Ward, Associate Chief Physician Long-term engagement in thoracic oncology medical treatment and clinical research, with extensive clinical experience in the comprehensive treatment of lung cancer, managing over 1,800 lung cancer patient consultations annually. Served as Principal Investigator (PI) for one national multicenter clinical study on lung cancer, and as Sub-PI for over 20 domestic and international multicenter oncology drug studies, possessing rich experience in clinical research and drug development for lung cancer and other solid tumors. Published more than 10 related papers as first author or corresponding author in journals such as *European Journal of Cancer* and *The Innovation Medicine*, and participated in and led multiple national, provincial, and ministerial-level research projects. Current positions include: Member of the International Association for the Study of Lung Cancer (IASLC), Member of the Oncology Genetics Group of the Medical Genetics Physician Branch of the Chinese Medical Doctor Association, Member of the Thoracic Oncology Branch of the China Association of Geriatric Health, Member of the Precision Medicine Expert Committee of the Tumor Rehabilitation Branch of the Chinese Society of Gerontology and Geriatrics, and Member of the Lung Cancer Subcommittee of the Beijing Cancer Prevention and Treatment Research Association.